WILMINGTON, Delaware, April 1 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial New late-breaking clinical trial data presented at ACC and published simultaneously in JACC show benefit of investigational medicine AZD0780 on top of standard of care Positive results from the PURSUIT Phase IIb trial for AstraZeneca's AZD0780 demonstrate  more

ALBANY, New York, April 4 -- The New York State Department of Environmental Conservation issued the following news release: * * * DEC Announces Temporary Closure of Skinners Falls Fishing Access Site on Upper Delaware River The New York State Department of Environmental Conservation (DEC) today announced the temporary closure of the Skinners Falls Fishing Access Site along the Upper Delaware River in the town of Cochecton, Sullivan County. The site is closed to the public through May 2025 due  more

WILMINGTON, Delaware, April 2 -- DuPont issued the following news release: * * * DuPont Launches New Liveo Pharma TPE Ultra-Low Temp Tubing for the Biopharma Industry WILMINGTON, Del., April 1, 2025 - DuPont (NYSE:DD) today announced it has launched DuPont Liveo Pharma TPE Ultra-Low Temp Tubing, a new thermoplastic elastomer tubing designed to withstand the low temperatures required for many of today's biopharmaceutical processing applications. Sterilizable, weldable, sealable Liveo Pharma T  more

BUFFALO, New York, April 4 -- The University at Buffalo (State University of New York) issued the following news release: * * * Global scholars to attend conference at UB exploring media's effects on morality By Bert Gambini BUFFALO, N.Y. - Some of the world's leading researchers working at the intersection of media and morality will be at the University at Buffalo from April 11-13 for this year's Moral Media Conference. The conference opens with a reception for attendees on April 11 at the  more

PITTSBURGH, Pennsylvania, April 3 -- Highmark, a health insurance company, issued the following news release: * * * Highmark Releases 2024 Bright Blue Futures Community Report PITTSURGH (April 3, 2025) -- Highmark today unveiled its 2024 Community Report, showcasing the significant impact of its Highmark Bright Blue Futures program. The report details how the corporate giving and community involvement program advanced the health and resilience of individuals, families, and communities across  more

WILMINGTON, Delaware, April 1 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * IMFINZI (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer Based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death vs. neoadjuvant chemotherapy alone AstraZeneca's IMFINZI (durvalumab) in combination with gemcitabine and ci  more

DELAWARE, Ohio, April 5 -- Ohio Wesleyan University issued the following news release: * * * Improving OWU Ohio Wesleyan Adding Student Hub, Removing Unused Building as Residential Renewal Continues DELAWARE, Ohio - Donor- and grant-funded work is underway at Ohio Wesleyan University to continue improving the residential campus for OWU students. The university is transforming former office space and student housing at 4 Williams Drive to create an on-campus hub that will feature billiards,   more

DELAWARE, Ohio, April 1 -- Ohio Wesleyan University issued the following news release: * * * Insights Into Evolution Ohio Wesleyan Professor Contributes to New Research Published in Nature Physics Journal DELAWARE, Ohio - Ohio Wesleyan University's Hanliang "Han" Guo, Ph.D., is the co-author of newly published research that "potentially provides fundamental insights of early evolution of multicellular organization." The research, "Cooperative hydrodynamics accompany multicellular-like colon  more